The Journal of Organic Chemistry
Note
MeTHF (10 mL/g), and AcOH (1.2 mL, 21.5 mmol) was added.
Tetra n-butylammonium fluoride solution (1 M in THF, 21 mL, 21
mmol) was added, and the mixture was stirred for 10 min. One molar
aqueous K2CO3 solution (24 mL) was added, and the mixture was
stirred for 30 min. The phases were separated, and the organic phase
was washed with water (3 × 25 mL). The organic solution was dried
over anhydrous Na2SO4 and evaporated to yield the product, which
was purified by chromatography or crystallized.
butylpiperidine yielded 0.58 g (65.8%) of 6d as a single diastereomer
as an oil after chromatography on silica (8:1 heptane/EtOAc): FT-IR
(SB-DC) cm−1 3379, 1661, 814; 1H NMR (400 MHz, CDCl3) δ
4.24−4.44 (m, 1H), 4.19−3.93 (m, 1H), 3.23−3.03 (m, 1H), 2.93−
2.76 (m, 1H), 2.29−2.18 (m, 1H), 2.17−1.84 (m, 4H), 1.69−1.49 (m,
1H), 1.44 (s, 9H), 1.37−1.15 (m, 4H), 0.94−0.88 (m, 3H); 13C NMR
(100 MHz, CDCl3) δ 154.7, 154.4, 109.3, 81.2, 81.2, 79.7, 79.6, 50.0,
49.0, 35.1, 33.9, 33.0, 32.4, 31.6, 31.5, 31.2, 29.1, 28.3, 22.5, 22.3, 14.0;
HRMS (GC-ESI) calcd for C10H19Cl3NO [(M − BOC + H)+] m/z
274.0532, found 274.0523.
Benzyl 4-(Trichloromethyl)-4-(trimethylsilyloxy)piperidine-
1-carboxylate (5a). Following Procedure A, 5.0 g (21.4 mmol) of
CBZ-4-piperidinone yielded 8.92 g (98%) of 5a after filtration through
a short plug of silica with 2:1 heptane/EtOAc as an oil that crystallized
Trimethyl(1,1,1-trichloro-4-phenylbutan-2-yloxy)silane
(7a).6 Following Procedure A, 0.94 g (7 mmol) of hydro-
cinnamaldehyde yielded 1.95 g (85.5%) of 7a as a colorless oil after
chromatography on silica eluting with 98:2 heptane/EtOAc: FT-IR
1
on standing: mp 71.4−74.7 °C; FT-IR (SB-DC) cm−1 1700, 838; H
NMR (400 MHz, CDCl3) δ 7.29−7.44 (m, 5H), 5.16 (s, 2H), 4.13−
4.36 (m, 2H), 2.90−3.08 (m, 2H), 1.92−2.20 (m, 4H), 0.27 (s, 9H);
13C NMR (100 MHz, CDCl3) δ 154.8, 136.5, 128.4, 127.9, 84.6, 67.2,
1
(SB-DC) cm−1 863, 837; H NMR (400 MHz, CDCl3) δ 7.36−7.26
(m, 5H), 4.17 (dd, J = 9.3, 1.9 Hz, 1H), 2.98 (ddd, J = 14.0, 10.6, 5.0
Hz, 1H), 2.69 (ddd, J = 13.7, 10.3, 6.5 Hz, 1H), 2.53−2.42 (m, 1H),
2.13−2.00 (m, 1H), 0.31 (s, 9H); 13C NMR (100 MHz, CDCl3) δ
140.8, 128.5, 128.3, 126.2, 103.8, 83.7, 34.6, 32.4, 0.8; LRMS-EI calcd
for C13H20Cl3OSi [(M + H)+] m/z 325, found 325.
40.0, 31.8, 31.6, 2.4; HRMS (GC-ESI) calcd for C17H25Cl3NO3Si [(M
+ H)+] m/z 424.0669, found 424.0664.
Benzyl 4-Hydroxy-4-(trichloromethyl)piperidine-1-carboxy-
late (6a). Following Procedure B, 8.53 g of 5a yielded 7.12 g (97%) of
6a as an oil that crystallized on standing: mp 146.4−148.6 °C; FT-IR
(SB-DC) cm−1 3368, 1670, 820; 1H NMR (400 MHz, CDCl3) δ
7.30−7.50 (m, 5H), 5.15 (s, 2H), 4.12−4.34 (m, 2H), 3.06−3.24 (m,
2H), 3.03 (s, 1H), 2.05−2.11 (m, 2H), 1.89−2.05 (m, 2H); 13C NMR
(100 MHz, CDCl3) δ 155.1, 136.5, 128.5, 127.8, 108.8, 80.3, 77.2,
67.3, 39.8, 31.1; HRMS (GC-ESI) calcd for C14H17Cl3NO3 [(M +
H)+] m/z 352.0274, found 352.0272.
1-tert-Butyl 2-Methyl 4-hydroxy-4-(trichloromethyl)-
piperidine-1,2-dicarboxylate (6b). Following Procedure A, without
isolation of 6a and Procedure B, 2.79 g (10.84 mmol) of methyl 1-
BOC-4-oxopiperidine-2-carboxylate was chromatographed on silica
(2:1 heptane/EtOAc) to yield the product as a colorless oil that
partially solidified on standing. 1.15 g of the major diastereomer was
obtained as a solid and 1.28 g of a mixture of diastereomers was
isolated as an oil. Total yield 2.43 g (59%). 0.53 g of the starting
ketone was recovered. Major diastereomer: mp 166.7−168.0 °C; FT-
IR (SB-DC) cm−1 3380, 1747, 167, 818; 1H NMR (400 MHz, CDCl3)
δ 4.81−4.85 and 5.0−5.05 (2 multiplets, total 1H), 3.96−4.04 and
4.07−4.14 (2 multiplets, total 1H), 3.73 and 3.75 (2 singlets, total
3H), 3.15−3.38 (m, 1H), 2.71−2.87 (m, 1H), 2.29−2.40 (m, 1H),
1.94−2.16 (m, 2H), 1.43 and 1.48 (2 singlets, total 9H); 13C NMR
(100 MHz, CDCl3) δ 172.4, 172.2, 155.2, 154.9, 108.0, 80.67, 80.65,
80.1, 80.0, 52.49, 52.45, 52.41, 51.3, 37.7, 36.8, 32.2, 32.0, 30.2, 30.0,
28.3; HRMS (GC-ESI) calcd for C8H13Cl3NO3 [(M-BOC+H)+] m/z
275.9961, found 275.9961.
1,1,1-Trichloro-4-phenylbutan-2-ol (8a).23 Following Proce-
dure B, 0.326 g (1.0 mmol) of 7a yielded 0.225 g (91%) of 8a as a
colorless oil after chromatography on silica eluting with 93:7 heptane/
EtOAc: FT-IR (SB-DC) cm−1 3400, 807; 1H NMR (400 MHz,
CDCl3) δ 7.30−7.35 (m, 2H), 7.21−7.27 (m, 3H), 4.00 (ddd, J = 10.0,
5.5, 2.0 Hz, 1H), 3.02 (ddd, J = 13.7, 9.0, 4.7 Hz, 1H), 2.75−2.83 (m,
1H), 2.76 (dd, J = 5.5, 1.8 Hz, 1H), 2.36−2.44 (m, 1H), 1.95−2.06
(m, 1H); 13C NMR (100 MHz, CDCl3) δ 140.6, 128.6, 128.5, 126.3,
104.1, 82.0, 32.9, 31.9; LRMS-CI calcd for C10H11Cl3O [M+] m/z 252,
found 252.
Trimethyl(2,2,2-trichloro-1-cyclohexylethoxy)silane (7b).9
Following Procedure A, 0.79 g cyclohexanecarboxaldehyde (7.1
mmol) yielded 2.1 g (98%) of 7b as a colorless oil after
chromatography on silica eluting with 98:2 heptane/EtOAc: FT-IR
1
(SB-DC) cm−1 835; H NMR (400 MHz, CDCl3) δ 3.88 (d, J = 2.2
Hz, 1H), 2.02−2.13 (m, 2H), 1.72−1.80 (m, 2H), 1.64−1.70 (m, 2H),
1.08−1.40 (m, 5H), 0.23 (s, 9H); 13C NMR (100 MHz, CDCl3) δ
104.0, 87.9, 40.7, 33.5, 27.2, 26.8, 26.3, 26.1, 0.6; LRMS-CI calcd for
C11H22Cl3OSi [(M + H)+] m/z 303, found 303.
2,2,2-Trichloro-1-cyclohexylethanol (8b).2 Following Proce-
dure B, 0.304 g (1.0 mmol) of 7b yielded 0.217 g (94%) of 8b as a
colorless oil after chromatography on silica eluting with 92:8 heptane/
EtOAc: FT-IR (SB-DC) cm−1 3500, 806; 1H NMR (400 MHz,
CDCl3) δ 3.88 (dd, J = 6.6, 2.7 Hz, 1H), 2.70 (d, J = 6.6 Hz, 1H),
2.02−2.13 (m, 2H), 1.73−1.83 (m, 3H), 1.65−1.72 (m, 1H), 1.14−
1.50 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 104.2, 86.4, 39.9, 32.3,
26.7, 26.6, 26.1, 25.9; LRMS-CI calcd for C8H14Cl3O [(M + H)+] m/z
231, found 231.
Benzyl 4-Hydroxy-2-phenyl-4-(trichloromethyl)piperidine-
1-carboxylate (6c). Following Procedure A, without isolation of
5c, and Procedure B, 4.0 g (12.9 mmol) of 1-CBZ-4-oxo-2-
phenylpiperidine yielded after chromatography on a silica eluting
with 85:15 heptane/EtOAc, 2.82 g of the major diastereomer as an oil
that solidified on standing and 1.63 g of the minor diastereomer as a
solid. Total yield 4.45 g (80.2%). Major diastereomer: mp 130.1−
Trimethyl(1,1,1-trichlorodecan-2-yloxy)silane (7c). Following
Procedure A, 1.01 g (7.1 mmol) of nonaldehyde yielded 2.29 g (96%)
of 7c as a colorless oil after chromatography on silica eluting with 98:2
heptane/EtOAc: FT-IR (SB-DC) cm−1 881, 839; 1H NMR (400
MHz, CDCl3) δ 4.04 (dd, J = 9.4, 2.0 Hz, 1H), 2.00−2.08 (m, 1H),
1.63−1.73 (m, 1H), 1.50−1.59 (m, 1H), 1.25−1.36 (m, 11H), 0.90 (t,
J = 6.6 Hz, 3H), 0.25 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 104.1,
84.3, 32.3, 31.9, 29.44, 29.37, 29.2, 29.0, 26.3, 22.7, 14.11, 14.08, 0.7;
LRMS-CI calcd for C13H28Cl3OSi [(M + H)+] m/z 333, found 333;
HRMS (GC-ESI) calcd for C13H27Cl2SiO [(M + H − HCl)+] m/z
297.1208, found 297.1202.
1
131.9 °C; FT-IR (SB-DC) cm−1 3380, 1662, 814; H NMR (400
MHz, CDCl3) δ 7.18−7.53 (m, 10H), 5.82−5.66 (m, 2H), 5.29−5.12
(m, 2H), 4.43−4.26 (m, 1H), 3.50−3.33 (m, 1H), 2.89−2.76 (m, 1H),
2.72−2.62 (m, 1H), 2.29−2.12 (m, 1H), 2.08−1.94 (m, 1H); 13C
NMR (100 MHz, CDCl3) δ 155.6, 155.5, 128.6, 126.5, 125.0, 108.7,
80.4, 67.5, 67.3, 52.0, 51.6, 36.7, 33.9, 33.2, 30.9, 30.6; HRMS (GC-
ESI) calcd for C20H21Cl3NO3 [(M + H)+] m/z 428.0587, found
428.0583. Minor diastereomer: mp 156.6−157.6 °C; FT-IR (SB-DC)
1,1,1-Trichlorodecan-2-ol (8c).23 Following Procedure B, 0.325
g (1.0 mmol) of 7c yielded 0.24 g (94%) of 8c as a colorless oil after
chromatography on silica eluting with 95:5 heptane/EtOAc: FT-IR
(SB-DC) cm−1 3400, 812; 1H NMR (400 MHz, CDCl3) δ 4.01 (ddd, J
= 9.8, 5.9, 2.0 Hz, 1H), 2.69 (dd, J = 5.5, 1.6 Hz, 1H), 2.00−2.10 (m,
1H), 1.60−1.71 (m, 2H), 1.24−1.51 (m, 11H), 0.89 (t, J = 7.0 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 104.4, 83.0, 31.8, 31.5, 29.4,
29.3, 29.2, 26.1, 22.7, 14.1; LRMS-CI calcd for C10H20Cl3O [(M +
H)+] m/z 261, found 261.
1
cm−1 3380, 1667; H NMR (400 MHz, CDCl3) δ 7.0−7.4 (m, 10H),
5.14−5.18 (m, 1H), 5.1 (d, J = 12.5 Hz, 1H), 5.02 (d, J = 12.5 Hz,
1H), 4.40−4.07 (m, 1H), 3.36−3.47 (m, 1H), 3.04 (s, 1H), 2.39−2.54
(m, 3H), 2.02−2.14 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 156.0,
143.0, 136.4, 128.7, 128.3, 127.5, 125.5, 108.5, 81.1, 67.2, 53.1, 39.5,
37.1, 34.0; HRMS (GC-ESI) calcd for C20H21Cl3NO3 [(M + H)+] m/
z 428.0587, found 428.0584.
tert-Butyl 2-Butyl-4-hydroxy-4-(trichloromethyl)piperidine-
1-carboxylate (6d). Following Procedure A without isolation of 5d
and then Procedure B, 0.6 g (2.53 mmol) of 1-CBZ-4-oxo-2-
(3-(Benzyloxy)-1,1,1-trichloropropan-2-yloxy)-
trimethylsilane (7d). Following Procedure A, 2.02 g (6.9 mmol) of
3002
dx.doi.org/10.1021/jo3001063 | J. Org. Chem. 2012, 77, 2999−3004